As of 4:00pm ET
| -0.01 / -0.27%|
The 6 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a +198.10% increase from the last price of 3.69.
The current consensus among 6 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.